Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | USP2 | O75604 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | CASP1 | P29466 | 2/20 | 1.00 |
| ▸ | ESR1 | P03372 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | AR | P10275 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | PDE4A | P27815 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clofoctol SCHEMBL147809 | 1.00 | CYP3A4 (1.00) | CYP3A4MEN1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL71922 | 0.85 | CYP3A4 (0.73) | CYP3A4MEN1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL16656147 | 0.80 | CYP3A4 (0.66) | CYP3A4MEN1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL27365508 | 0.76 | CYP3A4 (0.61) | CYP3A4MEN1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL9082692 | 0.76 | CYP3A4 (0.60) | CYP3A4MEN1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL27365471 | 0.75 | CYP3A4 (0.60) | CYP3A4MEN1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL9814995 | 0.75 | KLF10 (0.68) | CYP3A4MEN1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL5964677 | 0.75 | CYP3A4 (0.65) | CYP3A4MEN1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL8163543 | 0.74 | MAPT (0.59) | CYP3A4MEN1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL10802800 | 0.74 | SMN1; SMN2 (0.58) | CYP3A4MEN1KMT2AUSP2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111858888-B | Multi-round dialogue system of check-in scene | 北京航空航天大学 | 2023-05-30 | — | — | CN | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| US-12473252-B2 | Processes for the preparation of deuterated D-serine | SUN PHARMACEUTICAL INDUSTRIES, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| EP-4570265-A1 | VACCINE FOR USE IN PREVENTING INFLAMMATORY CONDITIONS IN COWS | Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. (PL) | 2025-06-18 | — | — | EP | disclosed |
| US-12325707-B2 | Process for preparing enantiomerically enriched JAK inhibitors | SUN PHARMACEUTICAL INDUSTRIES, INC. (US) | 2025-06-10 | — | — | US | disclosed |
| US-20250042841-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2025-02-06 | — | — | US | disclosed |
| US-20240368166-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2024-11-07 | — | — | US | disclosed |
| WO-2024223624-A1 | NEW CLOFOCTOL FORMULATION | Institut National de la Santé et de la Recherche Médicale (FR) | 2024-10-31 | — | — | WO | disclosed |
| US-20240300963-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2024-09-12 | — | — | US | disclosed |
| US-12065395-B2 | Processes for the preparation of deuterated D-serine | SUN PHARMACEUTICAL INDUSTRIES, INC. (US) | 2024-08-20 | — | — | US | disclosed |
| EP-3426182-B1 | METHODS AND COMPOSITIONS FOR DENTAL TISSUE REPAIR AND/OR REGENERATION | HARVARD COLLEGE (US) | 2024-05-01 | — | — | EP | disclosed |
| CN-110234647-B | Oxabicycloheptanes for modulating immune responses | 利克斯特生物技术公司 | 2023-05-23 | — | — | CN | disclosed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | disclosed |
| US-11622929-B2 | Long lasting cosmetic compositions | LIVING PROOF, INC. (US) | 2023-04-11 | — | — | US | disclosed |
| US-20220306636-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2022-09-29 | — | — | US | disclosed |
| US-20220249741-A1 | METHODS AND COMPOSITIONS FOR DENTAL TISSUE REPAIR AND/OR REGENERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2022-08-11 | — | — | US | disclosed |
| CN-114828848-A | Intranasal dantrolene administration for the treatment of alzheimer's disease | 宾夕法尼亚大学理事会 | 2022-07-29 | — | — | CN | disclosed |
| US-20220213105-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2022-07-07 | — | — | US | disclosed |
| US-20220169595-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2022-06-02 | — | — | US | disclosed |
| WO-2022036030-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | CONCERT PHARMACEUTICALS, INC. (US) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12325707-B2 | Process for preparing enantiomerically enriched JAK inhibitors | JAK1, JAK2, JAK3 | CYP3A4 610/4885MEN1 3569/4885KMT2A 870/4885 |
| US-12473252-B2 | Processes for the preparation of deuterated D-serine | PSPH, SRR, DHPS | CYP3A4 2558/4885MEN1 821/4885KMT2A 3739/4885 |
| US-20220213105-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | JAK1, JAK2, JAK3 | CYP3A4 610/4885MEN1 3569/4885KMT2A 870/4885 |
| US-20240300963-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | JAK1, JAK2, JAK3 | CYP3A4 610/4885MEN1 3569/4885KMT2A 870/4885 |
| US-12065395-B2 | Processes for the preparation of deuterated D-serine | PSPH, SRR, DHPS | CYP3A4 2558/4885MEN1 821/4885KMT2A 3739/4885 |
| US-20220249741-A1 | METHODS AND COMPOSITIONS FOR DENTAL TISSUE REPAIR AND/OR REGENERATION | ICAM1, EPCAM, MKI67 | CYP3A4 4787/4885MEN1 4420/4885KMT2A 3615/4885 |
| US-11622929-B2 | Long lasting cosmetic compositions | FABP4, CUTA, PLIN5 | CYP3A4 4659/4885MEN1 3120/4885KMT2A 2402/4885 |
| US-20220169595-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | PSPH, SRR, DHPS | CYP3A4 2558/4885MEN1 821/4885KMT2A 3739/4885 |
| US-20240368166-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | JAK1, JAK2, JAK3 | CYP3A4 610/4885MEN1 3569/4885KMT2A 870/4885 |
| US-20220306636-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | JAK1, JAK2, JAK3 | CYP3A4 610/4885MEN1 3569/4885KMT2A 870/4885 |
| US-20250042841-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | PSPH, SRR, DHPS | CYP3A4 2558/4885MEN1 821/4885KMT2A 3739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.